|
|
Inhibition of membrane Na + channels by a type botulinum toxin at femtomolar concentrations in central and peripheral neurons
|
|
|
|
|
نویسنده
|
shin m.-c. ,wakita m. ,xie d.-j. ,yamaga t. ,iwata s. ,torii y. ,harakawa t. ,ginnaga a. ,kozaki s. ,akaike n.
|
منبع
|
journal of pharmacological sciences - 2012 - دوره : 118 - شماره : 1 - صفحه:33 -42
|
چکیده
|
Recent studies have demonstrated that the botulinum neurotoxins inhibit the release of acetylcholine,glutamate,gaba,and glycine in central nerve system (cns) neurons. the na + current (i na) is of major interest because it acts as the trigger for many cellular functions such as transmission,secretion,contraction,and sensation. thus,these observations raise the possibility that a type neurotoxin might also alter the i na of neuronal excitable membrane. to test our idea,we examined the effects of a type neurotoxins on i na of central and peripheral neurons. the neurotoxins in femtomolar to picomolar concentrations produced substantial decreases of the neuronal i na,but interestingly the current inhibition was saturated at about maximum 50% level of control i na. the inhibitory pattern in the concentration-response curve for the neurotoxins differed from tetrodotoxin (ttx),local anesthetic,and antiepileptic drugs that completely inhibited i na in a concentration-dependent manner. we concluded that a type neurotoxins inhibited membrane na +- channel activity in cns neurons and that i na of both ttx-sensitive and -insensitive peripheral dorsal ganglion cells were also inhibited similarly to a maximum 40% of the control by the neurotoxins. the results suggest evidently that a2ntx could be also used as a powerful drug in treating epilepsy and several types of pain. © the japanese pharmacological society.
|
کلیدواژه
|
A2 type neurotoxin (A2NTX); Botulinum toxin; Dorsal root ganglion (DRG) neuron; Hippocampal CA1 neuron; Na + channel
|
آدرس
|
research division for life sciences,kumamoto health science university,kumamoto 861-5598, Japan, research division for life sciences,kumamoto health science university,kumamoto 861-5598, Japan, research division for life sciences,kumamoto health science university,kumamoto 861-5598,japan,department of integrative physiology,graduate school of medical sciences,kyushu university,fukuoka 812-8582, Japan, research division for life sciences,kumamoto health science university,kumamoto 861-5598,japan,department of brain science and engineering,kyushu institute of technology,fukuoka 808-0196, Japan, research division for life sciences,kumamoto health science university,kumamoto 861-5598, Japan, human vaccine production department,chemo-sero-therapeutic research institute,kumamoto 860-8568, Japan, human vaccine production department,chemo-sero-therapeutic research institute,kumamoto 860-8568, Japan, human vaccine production department,chemo-sero-therapeutic research institute,kumamoto 860-8568, Japan, department of veterinary science,graduate school of life and environmental sciences,osaka prefecture university,osaka 598-8531, Japan, research division for life sciences,kumamoto health science university,kumamoto 861-5598, Japan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|